Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 63 publications
A tailored in vivo CRISPR screen identifies BAP1 as a potent tumor suppressor of sarcoma.
Journal: JCI insight
Published: June 30, 2026
Widespread Adoption of Precision Anticancer Therapies After Implementation of Pathologist-Directed Comprehensive Genomic Profiling Across a Large US Health System.
Journal: JCO oncology practice
Published: November 12, 2024
Clinical impact for advanced non-small-cell lung cancer patients tested using comprehensive genomic profiling at a large USA health care system.
Journal: ESMO real world data and digital oncology
Published: July 25, 2024
Pertuzumab Plus Trastuzumab in Patients With Biliary Tract Cancer With ERBB2/3 Alterations: Results From the Targeted Agent and Profiling Utilization Registry Study.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: May 15, 2024
Cobimetinib Plus Vemurafenib in Patients With Solid Tumors With BRAF Mutations: Results From the Targeted Agent and Profiling Utilization Registry Study.
Journal: JCO precision oncology
Published: December 14, 2023
Cancer's Dark Matter: Lighting the Abyss Unveils Universe of New Therapies.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: February 28, 2023
Combination Dabrafenib and Trametinib Versus Combination Nivolumab and Ipilimumab for Patients With Advanced BRAF-Mutant Melanoma: The DREAMseq Trial-ECOG-ACRIN EA6134.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: September 27, 2022
A phase Ib trial of pembrolizumab plus paclitaxel or flat-dose capecitabine in 1st/2nd line metastatic triple-negative breast cancer.
Journal: NPJ breast cancer
Published: August 11, 2022
Neoantigen T-Cell Receptor Gene Therapy in Pancreatic Cancer. Reply.
Journal: The New England journal of medicine
Published: August 10, 2022
Neoantigen T-Cell Receptor Gene Therapy in Pancreatic Cancer.
Journal: The New England journal of medicine
Published: June 01, 2022
Galunisertib plus neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer: a single-arm, phase 2 trial.
Journal: The Lancet. Oncology
Published: April 06, 2022
Last Updated: 09/26/2026